Logo
x

Search

Subscribe Now

Teva

Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

  • January 14, 2025
Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

  • October 4, 2024
Insights+ Key Biosimilars Events of May 2024

Insights+ Key Biosimilars Events of May 2024

  • June 4, 2024
Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

  • May 20, 2024
Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

  • April 17, 2024
Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of Neurology

Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of N...

  • October 17, 2023
Alvotech & Teva Reports the US FDA’s BLA Acceptance of AVT05 (Biosimilar, Simponi & Simponi Aria)

    Alvotech & Teva Reports the US FDA’s BLA Acceptance of AVT05 (Biosimilar, Simponi & Simponi Aria)

    • January 28, 2025
    Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

      Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

      • January 14, 2025
      Alvotech and Teva Reports the US FDA’s Approval for the Additional Presentation of Selarsdi (Biosimilar, Stelara)

        Alvotech and Teva Reports the US FDA’s Approval for the Additional Presentation of Selarsdi (Biosimilar, Stelara)

        • October 23, 2024
        PharmaShots Weekly Snapshots (October 07 – October 11, 2024)

          PharmaShots Weekly Snapshots (October 07 – October 11, 2024)

          • October 11, 2024
          Teva Reports the Acceptance of Regulatory Submissions for TVB-009P (Biosimilar, Prolia) by the US FDA and EMA

            Teva Reports the Acceptance of Regulatory Submissions for TVB-009P (Biosimilar, Prolia) by the US FDA and EMA

            • October 9, 2024
            PharmaShots Weekly Snapshots (September 30 – October 04, 2024)

              PharmaShots Weekly Snapshots (September 30 – October 04, 2024)

              • October 4, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.